William C Nation LPC

Recommended Articles

• Is Ovarian Cancer Terminal?

  Let’s answer the question first: It depends on the stage of the disease. There are four stages of ovarian cancer, and the third and fourth are the most dangerous. The bad thing is that most cases of ovarian cancer are diagnosed in the later stages of the disease, when little can be done to save...

• A Better Treatment Approach for Relapsing Remitting Multiple Sclerosis?

  Relapsing remitting multiple sclerosis (RRMS) is an aggressive, rapidly debilitating form of multiple sclerosis. Individuals with this type of MS experience deterioration at a quicker rate than other forms, and don’t have as many treatment options. In terms of treatment for all types of MS, the...

• Potential New Target Found for Ovarian Cancer Treatment

  Being diagnosed with any form of cancer is a scary event that can turn a person’s world upside down. While cancer is never good, there are certain forms of the disease that are more threatening than others.When it comes to women, especially post-menopausal women, endometrial cancer can be one of...

• The Connection Between Ulcerative Colitis and Male Sexual Function

  Almost 40 percent of men say their sexual desire has decreased because of their Irritable Bowel Disease (IBD); over 25 percent say IBD prevents them from having sex and about 20 percent of men say it’s caused problems for them during sex. IBD is a chronic condition that affects 1.6 million people,...

• Cognitive Dissonance and How It Works

  Cognitive dissonance definitionPsychologically speaking, cognitive dissonance is the mental discomfort (stress) that a person undergoes when he/she goes through simultaneous contradiction of ideas, values, or beliefs when doing something that runs counter to one or more of the ideas, values, or...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...